Breaking News Medical - Legal Updates

  • Asbestos Workers Union Joins New Medical Foundation's Quest for Cure of Asbestos and Benzene-Related Cancers (3/20/06)
Historical Alliance of Doctors and Mesothelioma Patients Argue that Bail Out Bill's Arbitrary Awards Caps Discriminate Against Younger Patients and Under-funds Medical Research. Click here to learn more!
mesothelioma asbestos
Doctor Patient Alliance: Thanks for Helping Asbestos Cancer Patients (2/19/06)
mesothelioma asbestos
Mesothelioma Medical Experts Oppose Asbestos Trust Fund, Saying FAIR Act Hurts More than Helps (2/9/06)
mesothelioma asbestos
Doctor-Patient Alliance Speaks Out Against Unfair/Arbitrary/Unworkable Bail Out Bill! (7/19/05)
mesothelioma asbestos
Talking Points on the FAIR Act (S. 852) and the Position of the Doctor-Patient Alliance (7/19/05)
mesothelioma asbestos
Read this! This policy treatise was sent to all 100 members of the US Senate. (7/1/05)
mesothelioma asbestos
Breaking Press Release, June 30, 2005: Call on Congress to Tailor Awards to Damages, Compensate Swiftly and Commit to Increased Funding for Research. "....Awards to mesothelioma patients and medical research funding are tragically trivial." (7/1/05)
mesothelioma asbestos
Click Here to view a copy of the letter sent to members of the US Senate. (7/1/05)
  • "Rational Versus Radical Therapy For Mesothelioma: A New Approach," Dr. Robert Cameron, UCLA Medical School, presented at MARF Symposium in Las Vegas, October 16, 2004. Copyright of Dr. Robert Cameron. Do not copy without permission (11/18/04)
  • Curing Mesothelioma: Who Will Take the Initiative? As presented by Roger G. Worthington at the First International Mesothelioma Symposium (10/14/04)
  • A Modest Proposal: Asbestos Bankruptcy Lawyers Must Invest Trust Money in A Cure. RGW,PC (8/27/04)
  • UCLA Proposes Comprehensive Mesothelioma Translational Research Program. RGW,PC (5/10/04)
  • FDA OKs Lilly Drug for Asbestos-Related Cancer (2/5/04)
    RGW notes big discrepancy in statistics on total cases diagnosed per year
  • Raising Hope - $500,000 Awarded for New Research to Cure Asbestos-Related Cancer (1/30/04)
  • ASCO Reports on Intracavitary Hyperthermic Chemo, FDG-PET Scan Prognostication, and Alimta/Cisplatin Quality of Life (6/12/03)
  • British Editorial: Randomized Controlled Trial Needed to Verify Whether Radical EPP Surgery Best Option for Mesothelioma (6/03)
  • MARF Proposes Legislation to Create $135 Million mesothelioma Program (4/28/03)
  • Asbestos-Cancer Treatments Expected to Improve with MARF Grants; Federal Government Asked to Assist in Developing Cure (12/16/02)
  • MARF Doctor Hails Alimta as "A New Standard Therapy" for Treating Mesothelioma; Lilly Makes Drug Available through Expanded Access Program. Indianapolis, Indiana, November 14, 2002 (11/20/02)
  • MARF's Third Round of Mesothelioma Research Funding Attracts Superb International Field (10/17/2002)
  • LA Times' Lisa Girion Reports on Rising Incidence of mesothelioma in "New Generation" of Non-Occupationally Exposed Population (household exposure, part time summer jobs, home remodeling). (5/9/02)
  • MARF Announces The Availability of Its Third Round of Mesothelioma Research Grant Funding (4/19/02)
  • A Blessing In Disguise: How a Painful Fall From an Ornery Horse Results in a Life-Saving Lung Cancer Surgery for 65 year old Asbestos Investigator. Dave "Punch" Worthington. Keizer, OR (1/14/02)

Insurance Companies Forecast Costs of Asbestos Claims

OLDWICK, N.J.--(BUSINESS WIRE)--May 7, 2001--The property/casualty industry may be facing a surge in asbestos claims that could Cumulatively cost the industry as much as $65 billion, according to a new report, ``Asbestos Claims Surge Set to Dampen Earnings for Commercial Insurers,'' released by A.M. Best Co.

This new estimate of ultimate asbestos-related losses is nearly two-thirds higher than A.M. Best's previous 1997 estimate of $40 billion for such costs.

Meanwhile, A.M. Best's estimate of the industry's ultimate environmental liabilities remains unchanged at $56 billion, pending further study later in the year. As a result, A.M. Best projects that the industry's ultimate asbestos- and environment-related losses are now expected to reach $121 billion, up 26% from A.M. Best's previous $96 billion estimate.

Asbestos has surpassed environmental to become the most significant and difficult mass tort issue for the property/casualty industry in terms of incurred losses to date, claims volume and ultimate dollar exposure.

Based on Footnote 27 data, the insurance industry's asbestos claims payments have increased dramatically, averaging nearly 15% during the past two years. Going forward, over the next three to five years, we expect this unfavorable payment trend to worsen, such that annual paid claims will increase by at least 20%. With asbestos-claim payments expected to grow for the majority of exposed insurers in 2001 and beyond, these trends portend significant future asbestos liabilities and earnings drag for the P/C industry for years to come.